Zimmer Biomet, NY Hospital Partner on Mobility Platform
![Zimmer Biomet, NY Hospital Partner on Mobility Platform](https://www.insideindianabusiness.com/wp-content/uploads/2021/09/20123894_G.jpg)
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowA remote healthcare management platform developed by Warsaw-based Zimmer Biomet Holdings Inc. (NYSE: ZBH) has gotten the attention of one of the largest orthopedic hospitals in the country.
Hospital for Special Surgery, a network of orthopedic hospitals headquartered in New York, has signed an exclusive agreement to utilize Zimmer’s mymobility, a digital platform designed to manage post-operative patient care.
The system works in conjunction with an Apple Watch and iPhone.
The orthopedic hospital says it will use the ZB technology to deploy its HSS Orthopedic Care Pathways, a list of pre-operative and post-operative care protocols for patients, such as exercises and follow-up care.
“During a time when it’s critical for healthcare professionals to find virtual approaches to safely care and connect with patients, partnership with hospitals like HSS will help make virtual care a new standard for orthopedic patients across the globe,” said Ivan Tomos, group president for global business at Zimmer Biomet.
By using the sensors on an Apple Watch, the digital platform can monitor a patient’s real-time activity, such as recording the number of steps taken and measuring heart rate, after surgery.
“Bringing mymobility with Apple Watch, combined with HSS Orthopedic Care Pathways, will not only enhance physician and patient communications while allowing patients to recover from home where appropriate but will also provide our patients with key mobility metrics and outcomes data,” said Leonard Achan, president of the Innovation Institute at HSS.
Zimmer Biomet says the goal is to utilize virtual care management while lowering the overall cost of care with in-person visits.
The company intends to commercially launch the platform worldwide in early 2021.